Home › Cases › Bowel Obstruction — Volvulus
Bowel Obstruction
Bowel Obstruction — Volvulus
6 questions
Question 1 · Caecal volvulus
Correct answer: Caecal volvulus — caecum rotates on its mesentery, migrates to LUQ. Younger patients than sigmoid volvulus
Why
Caecal volvulus: caecum rotates and migrates, often to the LUQ; patients are often younger than with sigmoid volvulus (30–60 years). No satisfactory endoscopic treatment: urgent surgery.
- Resection, usually right hemicolectomy; detorsion/fixation only for selected patients unfit for resection with viable bowel
- CT: ectopic caecum, small-bowel dilation
Key point
Caecal volvulus: younger patients, caecum migrates to LUQ. No endoscopic treatment — needs surgery (right hemicolectomy).
Question 2 · Gastric volvulus
Correct answer: Gastric volvulus — Borchardt's triad: epigastric pain + unproductive retching + inability to pass NGT. Stomach twists on itself
Why
Gastric volvulus: Borchardt's triad — severe epigastric pain, unproductive vomiting (cannot decompress), inability to pass NGT. CXR: double air-fluid level or stomach in chest. Associated with diaphragmatic defects (hiatus hernia, para-oesophageal hernia). Emergency endoscopic or surgical decompression.
Key point
Gastric volvulus: Borchardt's triad — epigastric pain + retching + NGT failure. CXR: stomach in chest. Emergency decompression.
Question 3 · Management of sigmoid volvulus with ischaemia
Correct answer: Stop endoscopy; urgent sigmoid resection, often Hartmann’s if unstable/high risk
Why
Nonviable sigmoid volvulus: stop endoscopy — perforation risk; urgent resection. Hartmann’s (resection + end colostomy) is often suitable if unstable/high risk; anastomosis is a selected surgical decision. Viable bowel: decompress, then same-admission colectomy if fit because recurrence is high.
Key point
Nonviable: stop endoscopy, urgent resection. Viable: decompress, then same-admission colectomy if fit.
Question 4 · Ogilvie's — neostigmine
Correct answer: IV neostigmine 2mg over 3-5 minutes (with atropine available). Efficacy 80-90%. Monitor for bradycardia
Why
Neostigmine inhibits acetylcholinesterase → increases colonic motility. After failed supportive treatment, exclude mechanical obstruction, ischaemia and perforation. Give 2 mg IV over 3–5 min, with cardiac monitoring, resuscitation support and atropine ready. Response can occur within minutes. Caution with bradycardia, bronchospasm or recent anastomosis; obtain specialist review. If unsuitable/ineffective → colonoscopic decompression.
Key point
ACPO: neostigmine 2 mg IV over 3–5 min, monitored with atropine/resuscitation support ready, only after contraindication review. Colonoscopic decompression if contraindicated or ineffective.
Question 5 · SEMS complications
Correct answer: Stent perforation — complication rate 3-8%. Requires emergency surgery
Why
SEMS complications: perforation (3-8%) — emergency surgery required. Migration (10%): stent moves distally, re-obstruction. Re-obstruction (10-15% at 3-6 months): tumour ingrowth through mesh. Perforation risk higher with bevacizumab (VEGF inhibitor). CREST trial: no increase in local recurrence with SEMS vs emergency surgery.
Key point
Stent + sudden pain/peritonism/free air: suspect perforation — urgent surgery. Avoid stenting during bevacizumab therapy.
Question 6 · Flatus tube insertion
Correct answer: Leave a flatus tube for 1–3 days with tube care and regular review; bridge to early colectomy if fit
Why
Flatus tube after sigmoid detorsion: maintain decompression and reduce immediate recurrence. ACPGBI: leave for 1–3 days, with tube care and regular review; check positioning and pressure injury. It is a bridge to same-admission sigmoid colectomy if fit, not definitive prevention.
Key point
After detorsion: flatus tube 1–3 days with regular tube care/review. Early colectomy if fit.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.